Outcomes

New Real World Evidence Shows that Long-acting Antipsychotics Reduce Risk of Mortality for Patients Living with Schizophrenia Compared to Oral Antipsychotics

January 18, 2018

BEERSE, Belgium, January 18, 2018 /PRNewswire/ —   The Janssen Pharmaceutical Companies of Johnson & Johnson announce results of new real world evidence from a study of almost 30,000 people, which supports the benefits of long-acting antipsychotics (LATs) in reducing the risk of mortality among patients with schizophrenia. LATs are associated with a 33% lower […]

Comprehend Systems Appoints New CEO in Response to Surging Demand for Clinical Intelligence Solutions; Enterprise Growth Expert to Scale Company and Expand Partner Ecosystem

November 20, 2017

Redwood City, Calif., November 13, 2017—Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, has named Terry Cunningham CEO.  Cunningham will focus on scaling Comprehend in response to explosive customer demand for solutions that reduce time and risk in clinical trials. Cunningham will also drive expanded partner programs to help sponsors achieve faster, better clinical […]

The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank

November 8, 2017

The AbVance project aims to accelerate biologics drug discovery by increasing knowledge of antibody structures in the public domain  The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D has announced today that its project to increase  knowledge of antibody (Ab) structures has reached its […]

Real-World Evidence Generation in a Big Data World is Causing Disruption

October 23, 2017

In the life science industry, demand is exploding for evidence generated through real-world data. Unfortunately, most companies haven’t significantly updated their methods for generating evidence in the past 25 years. Are you ready to handle the disruption? This ebook covers numerous issues from a variety of stakeholders, including data visualization capabilities, advanced analytics, rich data […]

Pfizer Follows up Successful Smoking Cessation App With Livingwith, an App for Cancer Patients

October 19, 2017

Two years after launching its smoking cessation app Quitter’s Circle, pharmaceutical company Pfizer is seeing impressive continued engagement with the app. It’s also applying the lessons learned from Quitter’s Circle toward other mobile health pursuits — including a recently-launched app for people living with cancer.   “We can do surveys right in the app,” Mark […]

Patient Centricity Works

October 18, 2017

Ensuring a patient-first strategy drives real results in commercial pharma Does patient centricity work? Actually, yes. There are increasing volumes of evidence that demonstrate that when you focus on the difference you make to patients, your commercial performance will improve. And, as other stakeholders adapt to the same economic conditions, driven by data and our ability to measure […]

Anthem, HealthCore and Boehringer Ingelheim Initiate World’s Largest Pragmatic Clinical Trial to Study People Living with COPD in a Real-World Setting

October 5, 2017

INDIANAPOLIS & RIDGEFIELD, Conn.–(BUSINESS WIRE)–The first patients have now enrolled in AIRWISE, the world’s largest ever pragmatic clinical trial in chronic obstructive pulmonary disease (COPD) to study how commonly prescribed medicines may reduce the occurrence of exacerbations of COPD.   Anthem, HealthCore and Boehringer Ingelheim Initiate World’s Largest PCT to Study COPD in a Real-World […]

Inovalon Announces Agreement with Daiichi Sankyo, Inc. to Support Outcomes-Based Contracting

September 21, 2017

BOWIE, Md., Sept. 21, 2017 (GLOBE NEWSWIRE) — Inovalon (NASDAQ:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced that it has entered into an agreement with Daiichi Sankyo, Inc., to understand the potential role of abuse-deterrent formulations of opioid medications […]

The Future of RWE Technology-Moving Beyond Rapid Cycle Analytics

August 31, 2017

Rapid-cycle analytic technologies represent an important advance in the pursuit of improved evidence generation practices – but this is only the first step. Learn how RWE technology is evolving through standardization, efficiency, and democratization of data.

Amgen and Humana Partner For Improved Health Outcomes And Efficiency

August 23, 2017

Two of the nation’s leading health organizations, health and well-being company Humana Inc. (NYSE: HUM) and biotechnology company Amgen (NASDAQ:AMGN), have teamed up to identify opportunities to improve health outcomes and improve efficiency by unlocking new insights from the real world health care experiences of Humana’s 13 million members. In the collaboration agreement between Amgen […]

FEEDBACK